The first three months of 2025 saw $4.1 billion in Medtech venture capital funding, the best quarterly performance in two years. The flow of deals is not slowing down, despite economic uncertainty. The latest weekly round of financing gives us more reasons to be optimistic – read more below.
Corvia Medical raises $55m to complete confirmatory heart shunt trial
The US-based trial began is currently underway at more than 65 institutions across three continents with 750 patients enrolled.
Increasing Corvia’s current funding to around $150m, the latest set of funds originated from the company’s existing investment syndicate of Third Rock Ventures, General Catalyst Partners, AccelMed, Lumira Ventures, along with two strategic investors.
Corvia CEO George Fazio
Ceryx Medical raises $15m to support bioelectronic pacemaker
The closing of the new funding round brings the total raised to $15 million to support its pacing technology.
BGF, Parkwalk Advisors, Development Bank of Wales (DBW), and BBI, the company’s leading investors, supported the financing. Ceryx says they share its vision for intelligent bioelectronic systems enhancing heart failure care.
CEO Stuart Plant
EBR Systems raises additional $13m to support leadless pacing tech
EBR Systems completed a security purchase plan to bring in about $13 million (A$20 million) in financing. Coupled with its latest financing, closed on 12 June, EBR Systems brought in just shy of $50 million. The company can use the funds to continue to accelerate commercialisation efforts for its WiSE pacing technology.
President and CEO John McCutcheon
Positrigo closes $8.5m funding round
Switzerland-based MedTech Positrigo closed a financing round valued at 7 million Swiss francs ($8.5 million U.S.).
With lead investors HealthCap and Navivo Capital in Europe, the company plans to accelerate production of its NeuroLF system for functional brain imaging using PET and focus on commercial rollout in the U.S. and Europe.
CEO Dr. Jannis Fischer
HealthTech startup Koios Care raises €1m for AI-powered platform
The funding round was led by Greek early-stage DeepTech investor Evercurious VC, with participation from Astylab Ventures, the imec.istart fund, and several angel investors, including those coordinated by HeBAN.
This will help Koios Care expand its digital health tool ‘Parkiwatch’ across European clinics, and support regulatory clearance efforts.
Co-founder and CEO Konstantinos Kyritsis
Fallouh Healthchcare wins grant for cardiac medical device
Fallouh Healthcare has been awarded a grant of £305,050 from Innovate UK to finalise a prototype of PerDeCT – Pericardial Device for monitoring cardiac output and the diagnosis of Tamponade.
The funding was awarded to Fallouh Healthcare as part of the Eureka Eurostars programme.
CEO Bruno Podesser
